Filing Details

Accession Number:
0001437749-17-016704
Form Type:
4
Zero Holdings:
No
Publication Time:
2017-10-03 16:37:59
Reporting Period:
2017-10-02
Accepted Time:
2017-10-03 16:37:59
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1427925 Acelrx Pharmaceuticals Inc ACRX Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1511368 G Lawrence Hamel C/O Acelrx Pharmaceuticals, Inc.
351 Galveston Drive
Redwood City CA 94063
Chief Development Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2017-10-02 10,161 $5.29 41,964 No 4 S Indirect See footnote
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Indirect See footnote
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 16,379 Direct
Footnotes
  1. Shares sold pursuant to a 10b5-1 plan.
  2. The Shares were sold at prices ranging from $5.10 to $5.50. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
  3. The Shares are held in the Hamel Revocable Living Trust.